Skip to content
Screener

Pacira BioSciences, Inc. PCRX Business Segments — Adjusted cost of goods sold

Similar metrics at other companies

Terex logo
TEXAerials — Adjusted cost of goods sold
$429M+10.3%
Terex logo
TEXES — Adjusted cost of goods sold
$308M+6.2%
Terex logo
TEXMP — Adjusted cost of goods sold
$318M+6.4%
Terex logo
TEXSV — Adjusted cost of goods sold
$355M
Perimeter Solutions logo
PRMFire Safety — Adjusted cost of goods sold
$19.2M+3.3%
Perimeter Solutions logo
PRMSpecialty Products — Adjusted cost of goods sold
$45.29M+100%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-11.9%
Enterprise value$1.26B+6.9%
P/E194.1×
P/S1.4×-0.2×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept pcrx:CostOfGoodsSoldAdjusted.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
Line itemThree Months Ended March 31, 20262025
Revenues$177,376$168,923
Less:
Adjusted cost of goods sold (1)34,77032,590
Adjusted research and development (1)25,36223,101
Adjusted selling and marketing (1)58,16655,571
Adjusted general and administrative (1)25,71220,609
Stock-based compensation (1)13,53914,553
Amortization of acquired intangible assets14,32214,322

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold?
Pacira BioSciences, Inc. (PCRX) reported business segments — adjusted cost of goods sold of $34.77M in Q1 2026.
How has Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold changed year-over-year?
Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold increased by 6.7% year-over-year, from $32.59M to $34.77M.
What is the long-term trend for Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold?
Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold has grown at a -7.9% compound annual growth rate (CAGR), from $174.86M to $136.78M.
What does business segments — adjusted cost of goods sold mean?
Reflects the direct costs attributable to the production of goods sold by the segment, adjusted to exclude non-recurring or non-cash items. It is a key indicator of manufacturing efficiency and the direct profitability of the segment's core product offerings.

Ask your AI about Pacira BioSciences, Inc.'s business segments — adjusted cost of goods sold.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude